|
Jul 27
|
Eli Lilly Says Weight-Loss Drug Helps Patients Lose 26% of Their Weight, More Than Rivals
|
|
Jul 27
|
50 Most Valuable Companies in the World by Market Cap
|
|
Jul 27
|
Eli Lilly vs. Novo Nordisk: What's the Better Weight-Loss Stock to Buy?
|
|
Jul 27
|
UPDATE 3-Lilly's obesity drug leads to about 26% weight loss in new studies
|
|
Jul 27
|
Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies
|
|
Jul 26
|
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
|
|
Jul 25
|
Biogen Stock Tumbles On Plans To Cut 11% Of Workforce; Tops Second-Quarter Estimates
|
|
Jul 25
|
Is Eli Lilly Stock Still a Top-Growth Play?
|
|
Jul 25
|
A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
|
|
Jul 25
|
Lilly Confirms Date and Conference Call for Second-Quarter 2023 Financial Results Announcement
|
|
Jul 25
|
Jim Cramer Reveals Why One Popular Investing Method Is a 'Sucker's Game'
|
|
Jul 25
|
25 Countries With Highest Rates of Obesity
|
|
Jul 25
|
Lilly Announces Extension of Tender Offer to Acquire DICE
|
|
Jul 25
|
The EV Truck War Is Officially On
|
|
Jul 24
|
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
|
|
Jul 24
|
With 86% ownership in Eli Lilly and Company (NYSE:LLY), institutional investors have a lot riding on the business
|
|
Jul 24
|
Eli Lilly and Company (LLY) Climbed on Investors’ Excitement on Novel Weight Loss Drugs
|
|
Jul 23
|
Pharma lobbying for weight loss drugs could soon pay off
|
|
Jun 28
|
Better Artificial Intelligence Stock: GSK or Eli Lilly?
|
|
Jun 27
|
Competition heats up in weight loss drug pills, injectables space
|